Michael T. Sheaff

机构：Barts Health NHS Trust, Royal London Hospital · ORCID：0000-0001-9189-0181

发表论文 240 篇 · 总被引 7445 次 · h-index 43

代表论文

• Guidelines for Pathologic Diagnosis of Mesothelioma: 2023 Update of the Consensus Statement From the International Mesothelioma Interest Group (2024 · Archives of Pathology & Laboratory Medicine · 被引 68)
• Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma (2024 · JAMA Oncology · 被引 59)
• Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome (2023 · European Journal of Human Genetics · 被引 59)
• Abstract CT007: Phase 2-3 trial of pegargiminase plus chemotherapy versus placebo plus chemotherapy in patients with non-epithelioid pleural mesothelioma (2023 · Cancer Research · 被引 8)
• A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma (2023 · Pharmacological Reports · 被引 5)
• Identification and management of diabetic nephropathy (2023 · Medicine · 被引 5)